The relative role of ErbB1–4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells
- 15 March 2001
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 20 (11) , 1388-1397
- https://doi.org/10.1038/sj.onc.1204255
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 37 references indexed in Scilit:
- Activation of the c-fos enhancer by the Erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sitesOncogene, 2000
- Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cellsOncogene, 1999
- Ionizing Radiation Stimulates Existing Signal Transduction Pathways Involving the Activation of Epidermal Growth Factor Receptor and Erbb-3, and Changes of Intracellular Calcium in A431 Human Squamous Carcinoma CellsJournal of Receptors and Signal Transduction, 1999
- Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2Oncogene, 1997
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- Epidermal Growth Factor (EGF)-induced Generation of Hydrogen PeroxideJournal of Biological Chemistry, 1997
- Involvement of ErbB2 in the Signaling Pathway Leading to Cell Cycle Progression from a Truncated Epidermal Growth Factor Receptor Lacking the C-terminal Autophosphorylation SitesPublished by Elsevier ,1996
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer researchBreast Cancer Research and Treatment, 1995
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994